Merit Medical Systems (MMSI) Liabilities and Shareholders Equity (2009 - 2026)

Merit Medical Systems has disclosed Liabilities and Shareholders Equity across 18 years of filings, most recently posting $2.7 billion for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $2.7 billion, up 10.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.6 billion (up 10.23% YoY), and the FY2025 annual result was $2.7 billion, up 11.05% from the prior year.
• Liabilities and Shareholders Equity came in at $2.7 billion for Q1 2026 at Merit Medical Systems, up from $2.7 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.7 billion in Q1 2026 to a low of $1.6 billion in Q1 2022.
• The 5-year median for Liabilities and Shareholders Equity is $2.3 billion (2024), against an average of $2.2 billion.
• Across the five-year window, Liabilities and Shareholders Equity fell 1.33% in 2022 and soared 39.74% in 2023, its largest moves.
• Merit Medical Systems' Liabilities and Shareholders Equity stood at $1.7 billion in 2022, then soared by 39.74% to $2.3 billion in 2023, then grew by 4.02% to $2.4 billion in 2024, then advanced by 11.05% to $2.7 billion in 2025, then increased by 1.24% to $2.7 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $2.7 billion (Q1 2026), $2.7 billion (Q4 2025), and $2.6 billion (Q3 2025), per Business Quant data.